C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors
Abstract:
The invention relates to C-3 novel triterpenone with C-17 reverse amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.
Information query
Patent Agency Ranking
0/0